Procort, formulated by Skinvisible’s patented polymer delivery system Invisicare, is a kind of topical steroid that helps in reducing swelling, redness, allergic reactions and itching.
Earlier, Skinvisible has licensed Women’s Choice Pharma to commercialize its product in the US.
As per the deal, Skinvisible has received a development fee and now eligible to receive a license fee from Women’s Choice Pharma paid in milestones plus on-going royalties based on product sales.